Skip to Content

MYLAN FE 134 MYLAN FE 134 (Fenofibrate (Micronized) 134 mg)

Pill with imprint MYLAN FE 134 MYLAN FE 134 is Orange & White, Capsule-shape and has been identified as Fenofibrate (Micronized) 134 mg. It is supplied by Mylan Pharmaceuticals Inc..

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 134 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN FE 134 MYLAN FE 134

Fenofibrate (micronized) 134 mg MYLAN FE 134 MYLAN FE 134

Fenofibrate (Micronized)

Imprint:
MYLAN FE 134 MYLAN FE 134
Strength:
134 mg
Color:
Orange & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
silicon dioxide
corn starch
croscarmellose sodium
D&C Yellow No. 10
FD&C Yellow No. 6
gelatin
lactose
magnesium stearate
povidone
sodium lauryl sulfate
titanium dioxide
ferrosoferric oxide
potassium hydroxide
propylene glycol
shellac
ammonia
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide